Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Manager, Compliance Monitoring & Data Analytics is responsible for planning, executing, and continuously improving Revolution Medicines' Compliance risk-based Monitoring and Data Analytics Program. This individual will lead the evolution of compliance monitoring through advanced analytics, automation, continuous monitoring, and data-driven risk identification to strengthen the Company's Compliance Program. The successful candidate will lead compliance monitoring activities across Commercial, Medical Affairs, Clinical Development, Regulatory, Market Access, Patient Services, Finance, Human Resources, Legal, and other business functions to evaluate compliance risks, identify opportunities for improvement, and promote a culture of ethics and integrity. This individual will serve as a strategic business partner, leveraging data analytics to proactively identify compliance risks, recommend practical improvements, and support commercialization as Revolution Medicines continues to grow and expand globally. This role will report to the Sr. Compliance Director.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior